Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

What is Prostatitis?

What is the PCA3 Test?

Gold Nanoparticles Use in Prostate Cancer

Survival rates of prostate cancer

Precancerous conditions of the prostate

Prostate Cancer Diagnosis

Prostate Cancer Staging

Prostate Cancer Epidemiology Worldwide

Prostatitis symptoms

Rectal Examination for Prostate Cancer

Radiation therapy for prostate cancer

See more featured articles »

What is Prostatectomy?

Vasectomy and prostate cancer: Myth or reality?

Choosing the best treatment of prostate cancer - by stage

Symptoms of Benign Prostatic Hyperplasia (BHP)

The International Prostate Symptoms Score (IPSS)

Prostate Cancer Epidemiology

Breakthroughs in Prostate Cancer Treatments

PSA Test in Men Who Have Been Treated for Prostate Cancer

Prostate Cancer and Genetics

Gallium Ga 68-labeled PSMA-11 PET/CT Imaging for Prostate Cancer

Prostate Cancer and Exercise

Diagnosis of Benign Prostatic Hyperplasia (BPH)

Prostate Cancer Symptoms

Prostate Cancer and Diet

Prostate Cancer Risk Factors

Prostate Cancer Screening

Treatment of Benign Prostatic Hyperplasia (BHP)

Recent Genetic Breakthroughs in Prostate Cancer Research

Causes of benign prostatic hyperplasia

Brachytherapy for Prostate Cancer

What Should You Avoid Before a PSA Test?

The Prostate

Should MRI be Used to Diagnose Prostate Cancer?

Treatment of prostatitis

Prostate Cancer Cell Dormancy and Activation

Palliative treatment and end of life care for prostate cancer

Diagnosis of prostatitis

What is the Gleason Score?

PSA False Positive and False Negative Results

Prostate cancer complications

Causes of prostatitis

Prostate Biopsy

Prostate Cancer Questions

Hormonal therapy for prostate cancer

Prostate Cancer Partin Tables

Differentiating between prostate cancer and prostate enlargement

What is medical castration?

What is TURP?

Can Curcumin Prevent or Treat Prostate Cancer?

Prostate cancer prevention

Prostate Cancer Treatment

Cryosurgery for prostate cancer

What is the PSA Test?

Life after prostate cancer treatment

Single Nucleotide Polymorphisms and Prostate Cancer

What is benign prostatic hyperplasia?

Prostate Cancer Research

Types of PSA Test

Prostate cancer alternative and complementary therapies

Latest Prostate Cancer News and Research

Senescent neutrophils promote tumor survival across cancer types

Renowned as first responders to threatening infections, neutrophils also happen to feature prominently in the microenvironment of tumors, where they and other immune cells play opposing and frequently mutable roles in promoting-or resisting-cancer progression.

6 Feb 2026

Oxybutynin shows promise in managing hot flashes for prostate cancer patients

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to treat overactive bladder symptoms, reduces hot flashes compared to the placebo in men receiving hormone therapy for prostate cancer.

2 Feb 2026

Time of radiotherapy can influence the effectiveness of cancer treatment

A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Seville, in collaboration with the Virgen Macarena University Hospital, have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks.

30 Jan 2026

Novel laser focal therapy device shows promising results for prostate cancer treatment

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain patients.

28 Jan 2026

New trial tests strategies to protect heart health during prostate cancer therapy

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.S. News & World Report, has opened a phase 2 clinical trial comparing three different strategies for protecting heart health in prostate cancer patients who receive androgen deprivation therapy (ADT), a potentially lifesaving hormone therapy.

26 Jan 2026

Metabolic reprogramming drives prostate cancer progression and treatment resistance

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy (ADT), the disease often progresses to castration-resistant prostate cancer (CRPC).

24 Jan 2026

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a substantial rise in medication treatments, such as chemotherapy, immunotherapy, and hormone therapy, used before surgery to treat many cancers, often allowing less invasive surgery and helping clinicians assess how a patient's cancer responds to medication to guide the most effective treatment options.

22 Jan 2026

PSA-based tool improves decision making for prostate cancer screening and treatment

Prostate cancer is the second-leading cause of cancer death in American men.

16 Jan 2026

Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether combining precision radiation with a targeted radioactive therapy drug can help patients with recurrent prostate cancer delay progression, while delaying or avoiding the side effects of long-term hormone therapy.

16 Jan 2026

Cancer mortality drops 34% as treatments and early detection improve

The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and mortality across different populations.

16 Jan 2026

Common food preservatives may raise cancer risk

Higher intake of certain food preservatives is associated with increased cancer rates, particularly breast and prostate cancers, highlighting safety concerns.

13 Jan 2026

AI trained on sleep data predicts future disease and mortality years in advance

The SleepFM model reveals how sleep analysis can predict disease risk, offering insights into sleep's role as a vital health indicator for early intervention.

8 Jan 2026

Advanced AI provides accurate guidance for prostate cancer patients

Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large language model to provide accurate, patient-specific prostate cancer education.

7 Jan 2026

Dietary exposure to food preservatives associated with higher cancer incidence

Higher intake of food preservatives, widely used in industrially processed foods and beverages to extend shelf-life, is associated with a modestly increased risk of cancer, finds a study from France published by The BMJ today.

7 Jan 2026

Breakthrough treatment for advanced prostate cancer could eliminate severe side effects

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy.

7 Jan 2026

AI model can predict a person's disease risk using sleep data

A poor night's sleep portends a bleary-eyed next day, but it could also hint at diseases that will strike years down the road.

6 Jan 2026

New trial aims to improve both survival and quality of life for men with advanced prostate cancer

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance A032304) to explore whether doctors can optimize the timing of targeted radiation therapy to minimize side effects while preserving efficacy in men with advanced prostate cancer.

5 Jan 2026